Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Current Respiratory Care Reports|November 9, 2012
Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observational cohortBradley E Chipps, Robert S Zeiger, Alejandro Dorenbaum, et al.
The Journal of Allergy and Clinical Immunology|June 15, 2012
Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) studyBradley E Chipps, Robert S Zeiger, Larry Borish, et al.
The Journal of Allergy and Clinical Immunology|April 22, 2003
Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitisUlrich Wahn, Eli O Meltzer, Albert F Finn, et al.
The Journal of Allergy and Clinical Immunology|May 14, 2003
First do no harm: managing antihistamine impairment in patients with allergic rhinitisThomas B Casale, Michael S Blaiss, Erwin Gelfand, et al.
The World Allergy Organization Journal|June 13, 2014
International consensus on (ICON) anaphylaxisF Estelle R Simons, Ledit Rf Ardusso, M Beatrice Bilò, et al.
Current Opinion in Allergy and Clinical Immunology|June 30, 2012
2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxisF Estelle R Simons, Ledit R F Ardusso, M Beatrice Bilò, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|February 24, 2015
Insights and advances in chronic urticaria: a Canadian perspectiveGordon Sussman, Jacques Hébert, Wayne Gulliver, et al.
CMAJ Open|April 27, 2017
Characteristics and outcomes of Canadian MD/PhD program graduates: a cross-sectional surveyMichael A Skinnider, Jordan W Squair, David D W Twa, et al.
The Journal of Allergy and Clinical Immunology|August 11, 2007
Risk assessment in anaphylaxis: current and future approachesF Estelle R Simons, Anthony J Frew, Ignacio J Ansotegui, et al.
Pageof 16